Starting from these data, Uchima et al. [94] suggested that GM inhibited the invasiveness, proliferation, and potential liver metastatic of pancreatic cancer cell lines by downregulating TAT and uPA activities, reducing PAR-2 activation, and inhibiting the production of TGF-β1 and VEGF. Here, TGFB1 is linked to pancreatic neoplasm.